Global Single-use Bioprocessing Systems Market was Valued at US$ 2.80 Billion in 2018 and is Predicted to Grow at a CAGR of 17.2% from 2018 to 2027
The term "single-use bioprocessing system" refers to a method of bioprocessing in which systems such as disposable bioreactors, single-use bags, and disposable filters are discarded after use rather than being cleaned or sterilized. Single-use systems are widely used in upstream and downstream bioprocessing because of their advantages over traditional bioprocessing systems, such as lower costs, faster deployment, and lower danger of cross-contamination.
Furthermore, rising adoption of single-use bioprocessing systems, increased government and private sector investment in research and development (R&D), rising demand for single-use systems in the biopharmaceutical sector, and an increasing number of key players offering technologically advanced bioprocessing products are expected to drive the Single-use Bioprocessing Systems Market over the forecast period.
Single-use equipment has a number of advantages that help to improve the efficiency and cost-effectiveness of the biomanufacturing process. Because of their ability to offer significant cost savings, ease of disposal, time savings, less energy and water demand for the bioprocessing process, less danger of contamination, and increased productivity, single-use technologies are fast evolving and being embraced. The Single-use Bioprocessing Systems Market is Predicted To Grow due to the adoption of single-use bioprocessing technologies. Growing demand for biologics, the need to expand manufacturing capacity, the patent expiration of blockbuster compounds, and a limited number of possible drugs in the pipeline have pushed corporations to adopt new technologies including single-use bioprocessing systems.
Furthermore, rising government and private sector investment in medicinal, biopharmaceutical, and clinical diagnostics research and development are predicted to drive demand for efficient and cost-effective bioprocessing pilot study plants using Single-use Bioprocessing Systems Market. Pharmaceutical businesses in Spain, for example, spend US$ 1,154.7 million on research and development activities in 2014, according to Farmaindustria: the National Business Association of the Pharmaceutical Industry in Spain. More than half of the total money invested (US$ 591.9, 51.26 percent) was used to fund clinical studies, representing a 63 percent increase in investment over the previous decade (2004 to 2014).
Comments
Post a Comment